EXTEND Trial

Overview of attention for article published in Stroke, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

blogs: 1 blog
twitter: 6 X users

facebook: 1 Facebook page
reddit: 1 Redditor

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 53,298 followers.

RT @StrokeAHA_ASA: When Does Treatment Advancement Mean “It’s Time”? https://t.co/kLG47dsOmq #BloggingStroke contributor Richard Jackson di…

When Does Treatment Advancement Mean “It’s Time”? https://t.co/kLG47dsOmq #BloggingStroke contributor Richard Jackson discusses #Stroke article "EXTEND Trial: Towards a More Inclusive But Complex Thrombolysis" https://t.co/G8eQh85VJ9 https://t.co/giXbzlLN…

RT @StrokeAHA_ASA: EMERGING THERAPY CRITIQUES: EXTEND Trial: Towards a More Inclusive But Complex Thrombolysis #stroke https://t.co/Ui6c4ZC…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.